Health Condition 1: K802- Calculus of gallbladder without cholecystitis
Conditions
Interventions
Intervention1: Inj. Magnesium Sulphate (50% w/v) 30mg/kg diluted in 20ml of 0.9% normal saline.: Study participants will be randomized into two groups. Intervention group will receive Inj. Magnesium s
Sponsors
Rohan Deb
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of American Society of Anesthesiologists (ASA) grade I or II 2. Patients of age group 20-60 years.
Exclusion criteria
Exclusion criteria: 1. Patients with anticipated difficult intubation 2. Patients with hypermagnesemia 3. Patients with history of allergy to magnesium sulphate 4. Patients with severe hepatic, renal, endocrine dysfunction 5. Patients with cardiovascular disorder 6. Conversion to open procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Attenuation of hemodynamic changes to pneumoperitoneum such as systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and heart rate (HR)Timepoint: Outcome will be assessed starting from the point of administration of study drugs till 60 minutes post pneumoperitoneum. Data will then be assessed at the end of one year. | — |
Secondary
| Measure | Time frame |
|---|---|
| Documentation of side effects such as bradycardia, hypotension, if encounteredTimepoint: Outcome will be assessed starting from the point of administration of study drugs till 30 minutes post extubation. Data will then be assessed at the end of one year. | — |
Countries
India
Contacts
Public ContactLongjam Eshori
Regional Institute of Medical Sciences, Imphal
Outcome results
None listed